Stelexis BioSciences, Inc.

General Information

Company Name

Founded Year

2017

Location (Offices)

New York, United States +2

Founders / Decision Makers

Number of Employees

Industries

Funding Stage

Social Media

Stelexis BioSciences, Inc. - Company Profile

Stelexis is a Deerfield founded and solely funded New York-based cancer therapeutics company with a mission of transforming cancer therapeutics paradigm and patient care, through the discovery and development of novel drugs.

Funding Rounds & Investors of Stelexis BioSciences, Inc. (0)

View All

There is no investment information

Latest News of Stelexis BioSciences, Inc.

View All

No recent news or press coverage available for Stelexis BioSciences, Inc..

Similar Companies to Stelexis BioSciences, Inc.

View All

PIC Therapeutics Modulating Oncogene Translation to Dramatically Improve Cancer Patient Outcomes

SOLID Therapeutics An early-stage oncology company aiming to treat solid tumors

ViroCure ViroCure is at the forefront of cancer therapeutics research and vaccine development with oncolytic virotherapy.

Raze Therapeutics, Inc.

IRX Therapeutics Developing immune therapies to activate the body's natural defense against cancer and related diseases, aiming to enhance and extend patient lives.

Stelexis BioSciences, Inc. - Company Profile

Funding Rounds & Investors of Stelexis BioSciences, Inc. (0)

Latest News of Stelexis BioSciences, Inc.

Similar Companies to Stelexis BioSciences, Inc.

Want to dive deeper into Stelexis BioSciences, Inc.? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.